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 • TECHNICAL DEVELOPMENTS
Imaging of endovascular flow patterns in the abdominal aorta is challenging but clinically relevant because of the 
relationship between local hemodynamics and the devel-
opment of vascular diseases (1–3).
Conventional Doppler US enables a one-dimensional 
blood flow velocity estimate in the axial direction. How-
ever, because the aortoiliac bifurcation is perpendicular to 
the transducer, it is difficult to obtain reliable flow quan-
tification with Doppler imaging.
In the carotid artery and the heart, US particle im-
age velocimetry (hereafter, echo PIV) has been used 
to obtain two-dimensional velocity vector fields of 
blood flow in the axial and lateral directions (4,5). 
With this technique, US images are acquired and used 
for PIV analysis. Recent developments in the use of 
high-frame-rate (HFR) contrast material–enhanced 
(CE) US have improved the possibilities of quantify-
ing blood flow with echo PIV. However, flow velocities 
of approximately 1 m/sec, which can be found in the 
human abdominal aorta, have not been successfully 
quantified until recently (6).
In the abdominal aorta, US is complicated by loss of 
signal due to bowel gas or imaging depth, which could 
be compensated by using US contrast agents. However, 
little is known about the amount of contrast agent re-
quired for optimal PIV analysis. In vitro models at an 
imaging depth of 10 cm suggested the feasibility of ab-
dominal echo PIV with HFR CE US (7). The objective 
of this study was to investigate the feasibility of echo PIV 
to visualize blood flow in the human abdominal aorta by 
using phase-contrast MRI as a reference.
Materials and Methods
This prospective within-subject exploratory study evalu-
ated 15 healthy participants. US and MRI were per-
formed in all participants in February and March 2017, 
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Purpose: To study the feasibility of high-frame-rate (HFR) contrast material–enhanced (CE) ultrasound particle image velocimetry 
(PIV), or echo PIV, in the abdominal aorta.
Materials and Methods: Fifteen healthy participants (six men; median age, 23 years [age range, 18–34 years]; median body mass 
index, 20.3 kg/m2 [range, 17.3–24.9 kg/m2]) underwent HFR CE US. US microbubbles were injected at incremental doses (0.25, 
0.5, 0.75, and 1.5 mL), with each dose followed by US measurement to determine the optimal dosage. Different US mechanical 
index values were evaluated (0.09, 0.06, 0.03, and 0.01) in a diverging wave acquisition scheme. PIV analysis was performed via 
pairwise cross-correlation of all captured images. Participants also underwent phase-contrast MRI. The echo PIV and phase-contrast 
MRI velocity profiles were compared via calculation of similarity index and relative difference in peak velocity.
Results: Visualization of the aortic bifurcation with HFR CE US was successful in all participants. Optimal echo PIV results 
were achieved with the lowest contrast agent dose of 0.25 mL in combination with the lowest mechanical indexes (0.01 or 0.03). 
Substantial bubble destruction occurred at higher mechanical indexes (0.06). Flow patterns were qualitatively similar in the echo 
PIV and MR images. The echo PIV and MRI velocity profiles showed good agreement (similarity index, 0.98 and 0.99; difference 
in peak velocity, 8.5% and 17.0% in temporal and spatial profiles, respectively).
Conclusion: Quantification of blood flow in the human abdominal aorta with US particle image velocimetry (echo PIV) is feasible. 
Use of echo PIV has potential in the clinical evaluation of aortic disease.
© RSNA, 2018
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Abbreviations
CE = contrast material enhanced, HFR = high frame rate, PIV = particle 
image velocimetry
Summary
Flow patterns in the abdominal aorta can be assessed with high-frame-
rate contrast-enhanced US particle image velocimetry.
Implication for Patient Care
US particle image velocimetry has the potential to improve upon cur-
rent methods of quantitative diagnosis of vascular diseases.
with participants at rest in the supine position. Inclusion 
criteria were as follows: age of 18–35 years and body mass 
index of 25 kg/m2 or less. Exclusion criteria were as follows: 
hypersensitivity to the excipients in the US contrast agent 
(SonoVue; Bracco, Milan, Italy), known history of cardiore-
spiratory diseases, uncontrolled systemic hypertension, preg-
nancy, and standard MRI exclusion criteria.
Volunteers who met the entry criteria were included 
in the study after they provided written informed con-
sent. This study was conducted in accordance with Good 
Clinical Practice guidelines and was approved by an au-
thorized institutional review board in the Netherlands 
(NL58025.078.16).
HFR CE Echo PIV
Echo PIV was performed with a fully programmable Vantage 
256 US machine (Verasonics, Kirkland, Wash) with a curvilin-
ear array abdominal probe (C5–2; ATL, Bothell, Wash). Before 
US, physical examination was performed and blood flow ve-
locity in the distal abdominal aorta was measured with pulsed 
wave Doppler imaging by using an Epiq 7 US machine (Philips 
Healthcare, Best, the Netherlands).
A four-member research team performed the echo PIV 
measurements. The aortic bifurcation was visualized in a coro-
nal oblique view by an experienced vascular technologist. The 
Vantage 256 US machine was controlled by a researcher (J.V.). 
Contrast agent was injected by a physician with experience in 
Table 1: Overview of Activities for Each Study Participant
Examination and Duration Action
Examination 1: high-frame-rate CE US
 5 minutes Physical examination and blood pressure
 5 minutes Instructions and visualization of distal aorta
HFR control measurement (Vantage 256 machine)
 5 minutes Pulsed wave Doppler measurement (Epiq 7 machine)
 5 minutes Insertion of venous cannula
 4 3 2–3 minutes US contrast agent injections (0.25, 0.5, 0.75, and 1.5 mL)
HFR CE US measurements (Vantage 256 machine)
Examination 2: phase-contrast MRI
 10 minutes Instructions and imaging preparations
 1 hour Phase-contrast MRI 
Note.—CE = contrast enhanced, HFR = high frame rate. 
CE US examinations (P.T.). The Epiq 7 US machine was also 
used by a researcher (S.E.) for visual contrast monitoring in 
the left superficial femoral artery. A stable concentration of 
contrast agent was used for starting the HFR CE US measure-
ments, and subsequent injections were given only after sub-
stantial washout of the agent.
For each measurement, images were captured for 2.5 sec-
onds at 1000 frames per second using a three-angled diverging 
wave acquisition scheme. First, HFR measurement without 
contrast agent administration was performed. After this mea-
surement, four incremental contrast agent doses were admin-
istered to each participant (0.25, 0.5, 0.75, and 1.5 mL) to 
investigate the optimal dose for PIV analysis. An overview of 
the measurement scheme is given in Table 1.
Mechanical Index
Before the study, hydrophone pressure measurements were 
performed to guarantee that pressures in the ultrasound 
beam field were within safety limits (8) with the transducer 
at maximum transmitter voltage. Thereafter, transmitting 
voltage was set to 60% during the first participant measure-
ments. Four measurement sessions were planned, with three 
or four participants per session. In each subsequent measure-
ment session, the transmitter voltage was further reduced to 
investigate image contrast and microbubble behavior. The 
average mechanical index at a depth of 3–5 cm (depth of 
abdominal aorta) was calculated for each transmitter volt-
age used. By following this regimen, measurements were 
performed at mechanical indexes of 0.09, 0.06, 0.03, and 
0.01 (Table 2).
Data Analysis
Echo PIV data were processed offline. Singular value decom-
position–based clutter suppression was applied to each of 
the three transmit angles individually (9). PIV analysis was 
performed by means of blockwise cross correlation between 
like-angled transmissions in each image pair by using a modi-
fied version of the open-source software PIVlab (V1.41; W. 
Thielicke) (10). The mean of the three resulting correlation 
maps was used for displacement estimation. A four-iteration 
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cross-correlation approach was used, with a final block size of 
7 3 6 mm and 75% overlap. A 15-frame temporal moving 
average filter and 5 3 3 Gaussian spatial filter were applied 
for smoothing of the obtained velocity data.
An extensive comparison of contrast agent doses, mechani-
cal indexes,  US acquisition schemes, and postprocessing meth-
ods that were used in this study is reported elsewhere (11).
Phase-contrast MRI
All participants underwent phase-contrast 3.0-T MRI (Inge-
nia; Philips Healthcare) by using a phased-array torso coil 
within 1 month before or after echo PIV measurements. Mul-
tisection two-dimensional survey acquisitions were obtained 
to localize the distal aorta and iliac arteries. Subsequently, 
a three-dimensional acquisition was performed with free-
breathing retrospective vectorcardiography-gated gradient-
echo and echo planar imaging readout (repetition time msec/
echo time msec, 8.9/4.6; echo planar imaging factor, 5; flip 
angle, 10°). Standard four-point three-directional velocity 
encoding was used with Venc (maximum velocity encoding) 
of 150 cm/sec (12). The acquisition volume captured the aor-
toiliac bifurcation, including renal and external iliac arter-
Figure 1: Overview of the measurement and registration method for the US particle image velocimetry (echoPIV ) and phase-contrast MRI (PC-
MRI) data. Probe locations of temporal velocity profiles (○) and spatial velocity profiles (lines) are shown in red for PC MRI data and in blue for 
echo PIV data. HFR-CEUS = high-frame-rate contrast-enhanced US.
Table 2: Overview of Mechanical Index and Observations Concerning Bubble Destruction
Mechanical 
Index No. of Participants
Bubble Destruction
Adequate Contrast Signal 
for PIV Analysis
HFR CE US Images  
(Abdominal Aorta)
Conventional US Images  
(Superficial Femoral Artery)
0.09 4 Substantial destruction Substantial destruction No
0.06 3 Substantial destruction Substantial destruction No
0.03 4 Some loss of signal No visible destruction Yes
0.01 4 No visible destruction No visible destruction Yes
Note.—The velocity data of the participants measured with mechanical indices of 0.03 and 0.01 were used for comparison between US 
PIV and phase-contrast MRI. CE = contrast enhanced, HFR = high frame rate, PIV = particle image velocimetry.
ies, with 29 reconstructed 2-mm-thick sections, resulting in 
a voxel size of 1.8 3 1.8 3 2.0 mm. The cardiac cycle was 
reconstructed into 30 phases. True temporal resolution was 
35.6 msec (ie, 4 3 the repetition time).
Comparison of Echo PIV and Phase-contrast MRI 
Quantitative comparisons of echo PIV and phase-contrast 
MRI velocity data were performed. For image registration, an 
in-house software package (MASS) was used to visualize the 
three-dimensional phase-contrast MRI velocity data in manu-
ally selected planes that showed anatomic dimensions similar 
to the echo PIV images. Qualitative comparison of the velocity 
images was performed.
To extract velocity profiles, the phase-contrast MRI data 
were imported into Tecplot 360 EX (2016 R1; Tecplot, Bel-
levue, Wash), and a plane was selected by using the previously 
mentioned method. Further processing and comparison of 
the data were performed by using Matlab (R2016a; Math-
Works, Natick, Mass).
Temporal velocity profiles were extracted from both data sets 
in five locations on the centerline of the aorta at 1-cm intervals 
proximal to the bifurcation apex (Fig 1). The time axis of the 
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astole, retrograde flow was observed with both modalities 
in all participants except participants 2, 7, and 8. In par-
ticipants 2 and 8, only the echo PIV data showed backflow 
during diastole, while phase-contrast MRI data did not. The 
pulsed wave Doppler measurements agreed with the echo 
PIV measurements, showing a triphasic flow profile with a 
clear retrograde flow component. No significant retrograde 
flow was observed in participant 7 with either modality. In 
this participant, a period of relative blood stasis occurred 
during diastole. Flow patterns were similar in both the 
phase-contrast MRI and echo PIV data, including a recircu-
lation zone near the origin of the left common iliac artery 
during diastole (Fig 2).
Velocity Profiles
Temporal velocity profiles corresponded well between the 
echo PIV and phase-contrast MRI data sets (Fig 3). Mean 
similarity index was 0.98 (range, 0.96–0.99), and the mean 
difference in peak velocity was 8.5% (range, 0.09%–29%). 
Bland–Altman analysis is shown in Figure 4. Similar spa-
tial velocity profiles were also found with both modalities 
phase-contrast MRI data was matched to the echo 
PIV time axis. Spatial velocity profiles were extracted 
perpendicular to the centerline of the aorta in five lo-
cations 1–3 cm proximal to the bifurcation apex.
Cosine similarity between the shape of the tem-
poral and spatial velocity profiles of both data sets 





V V  
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where (VechoPIV,VMRI,) denotes the inner vector prod-
uct and |VechoPIV||VMRI| is the vector length. Similar-
ity index can range from 21 to 1, where a value of 
1 means two curves are colinear. Difference in peak 
velocity was calculated relative to the phase-contrast 
MRI data. Bland-Altman analysis was performed for 
the temporal peak velocities.
Results
Fifteen participants (six men) were included; 
their median age was 23 years (range, 18–34 
years), and their median body mass index was 
20.3 kg/m2 (range, 17.3–24.9 kg/m2). Contrast 
agent injections and HFR CE US measurements 
were successful in all participants. Adequate echo 
PIV results (in terms of cross correlation) were 
achieved in all participants for all contrast agent 
doses (Movie 1 [online]). Without the US con-
trast agent, insufficient signal for PIV analysis 
remained after clutter suppression.
Mechanical Index
Mechanical indexes of 0.09 and 0.06 showed sub-
stantial destruction of contrast agent microbubbles in the ab-
dominal aorta during echo PIV (Table 2). This resulted in con-
trast agent signals that were inadequate for PIV analysis during 
diastole. Bubble concentration was replenished during systole 
by new microbubbles entering the field of view. Contrast agent 
signal also decreased in the superficial femoral artery at the ex-
act time of the HFR CE US measurements (Movie 2 [online]).
With a mechanical index of 0.03, some bubble destruction 
was visible in the HFR CE US recordings, with no substantial 
signal decrease in the superficial femoral artery. Contrast agent 
signal during diastole was adequate for PIV analysis in these 
measurements. At a mechanical index of 0.01, no bubble de-
struction was observed.
As a result of contrast agent destruction, only the measurements 
with mechanical indexes of 0.03 and 0.01, which were performed 
in eight study participants, were used for comparison of echo PIV 
and phase-contrast MRI (with 0.25 mL of contrast agent).
Flow Assessment
Undisturbed forward blood flow was observed in all eight 
participants during systole for both modalities. During di-
Figure 2: Streamline representation of blood flow velocities during early di-
astole in participant 7. Similar flow patterns can be observed in both data sets, 
including a slow (counterclockwise) recirculation zone near the origin of the left 
common iliac artery. This recirculation zone occurred during a longer time period 
in the phase-contrast MRI (PC-MR) data (five of 30 phases) than in the US particle 
image velocimetry (echoPIV ) data (10–15 msec). Dashed lines show estimated 
delineation of the vessel wall.
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ment of prognostic factors of vascular disease, indications for 
treatment, and clinical follow-up.
A large range of blood flow velocities, including veloci-
ties greater than 1 m/sec during systole, and very slow flow 
rates or blood stasis can be registered. In addition, two-di-
mensional vector fields of blood flow velocity can be used to 
evaluate flow disturbances, which is not possible with con-
ventional Doppler imaging.
Analysis of the velocity profiles showed good overall 
agreement between the echo PIV and phase-contrast MRI 
data. Both techniques have similar spatial resolution (1.75 
3 1.5 mm vector resolution and 2.6-mm US section thick-
ness in echo PIV data versus 1.8 3 1.8 3 2.0 mm voxel 
size in phase-contrast MRI data), whereas the temporal 
resolution was 30 times higher for echo PIV (1000 frames 
per second in real time vs 30 phases per cardiac cycle with 
interleaved sampling in phase-contrast MRI data). Similar 
retrograde flow patterns were observed in six of eight partic-
ipants studied. In participants 2 and 8, retrograde flow was 
observed in the echo PIV data and pulsed-wave Doppler 
measurements but not in the phase-contrast MRI data. This 
could indicate that flow quantification with echo PIV was 
more accurate in these participants because of a higher tem-
poral resolution and no averaging of multiple heart cycles. 
However, the difference in flow patterns could also be ex-
plained by differences in body position or physiologic status 
of the participants during imaging.
Substantial bubble destruction occurred in the HFR CE US 
measurements with a mechanical index greater than or equal 
to 0.06. This caused a decrease in contrast agent signal that 
(Fig 5). Mean similarity index was 0.99 (range, 0.93–1), 
and the mean difference in peak velocity was 17.0% (range, 
4.6%–32.0%).
Discussion
This study shows that quantification of blood flow in the hu-
man abdominal aorta is possible with echo PIV, and velocity 
profiles and data correspond well with those seen with phase-
contrast MRI. This first-in-human study has demonstrated 
that assessment of flow patterns in the abdominal aorta is 
feasible, which can have major implications for the assess-
Figure 3: Temporal velocity profiles in eight participants. Shaded areas represent the range of measured velocities in the five probed locations. 
Difpeak = difference in peak velocity relative to phase-contrast MRI data, SI = similarity index. ∗ Participants in whom substantial backflow was found in 
the US particle image velocimetry data but not in the phase-contrast MRI data. ∗∗ Participant in whom no substantial backflow was found with either 
modality.
Figure 4: Bland–Altman plot of peak velocities in eight participants. 
Mean absolute difference between US particle image velocimetry 
(echo PIV) and phase-contrast MRI peak velocities is 24 cm/sec (echo 
PIV is 4 cm/sec lower). The 95% confidence interval ranges from 226 
to 18 cm/sec. The negative mean difference is mainly caused by one 
outlier in the data (volunteer 8). SD = standard deviation.
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rendered echo PIV results unreliable during diastole. These re-
sults were unexpected because no bubble destruction was ob-
served during in vitro testing with use of similar acquisition 
settings and maximum transmitter voltage (mechanical index 
' 0.15) (7). The reduced bubble stability in vivo could be at-
tributed to several physiologic conditions (temperature, gas ex-
change, pressure) that were not accounted for in vitro (13–15).
Image registration was performed by manual extraction of 
a two-dimensional plane from the phase-contrast MRI data 
to match the echo PIV data. The US insonification plane was 
not recorded and could therefore not be recreated in the volu-
metric phase-contrast MRI data. Neighboring phase-contrast 
MRI planes were evaluated, showing clear differences in ana-
tomic dimensions, whereas peak velocities showed differences 
of less than 10%. Thus, it is reasonable to assume that manual 
spatial matching of phase-contrast MRI and echo PIV data 
did not cause large differences in flow velocity.
In the echo PIV data, out-of-plane motion of US contrast 
agent and local imaging artifacts caused local decreases in cor-
relation values and subsequent errors in the velocity vector 
fields. These errors were reduced by spatial smoothing, but this 
also removed details in the vector fields.
For echo PIV to become a clinically viable technique, further 
development is required in terms of ease of use, real-time data 
visualization, and calculation of derived flow parameters. Fur-
thermore, prospective patient studies with echo PIV, in combi-
nation with long-term follow-up, are indicated to investigate the 
predictive value of these flow parameters.
In conclusion, quantification of blood flow in the abdomi-
nal aorta with echo PIV was performed in humans for the 
first time, demonstrating the feasibility of the technique. An 
Figure 5: Spatial velocity profiles in eight participants. Shaded areas represent the range of measured velocities in the five probe locations.  
Difpeak = difference in peak velocity relative to phase-contrast MRI data, SI = similarity index.
optimal balance between image contrast and bubble concen-
tration was found in a small cohort of healthy participants. 
The PIV velocity data showed good overall agreement with 
corresponding phase-contrast MRI data sets. Although it 
requires further development and validation, the echo PIV 
technique has great potential to enable quantitative diagnosis 
of vascular diseases and follow-up after treatment.
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